Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ipsen Expands In Oncology With New Pacts

French Firm Ups BD Activity

01 Aug 2022

• By Kevin Grogan

Ipsen — • Source: Alamy

Related Content

Ipsen Targets External Innovation With Exicure Option In Rare Neurodegenerative Disorders

03 Aug 2021

Ipsen Gives Genfit Liver Drug New Lease Of Life

17 Dec 2021

Ipsen Seeks Success Outside Big Pharma's Hunting Grounds

02 Mar 2022

Ipsen Hungry For More Deals After Swallowing Epizyme

27 Jun 2022

Ipsen To Exit Consumer Health And Focus On Specialty Pharma

11 Feb 2022

Related Companies

Ipsen SA

Epizyme, Inc.

Mayoly-Spindler SAS

BAKX Therapeutics Inc.

Exicure, Inc.

Genfit SA

Exelixis, Inc.

Additional Topics

Commercial Deals ImmunoOncology M & A Business Strategies Research & Development Cancer BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.